Security key
36338D108
Galera Therapeutics, Inc. - Common stock, par value $0.001 per share (the "Common Stock") (GRTX)
CUSIP: 36338D108
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Common stock, par value $0.001 per share (the "Common Stock")
- Total 13F shares
- 52,113
- Total 13F value
- $7,129
- Share change
- -9,729,427
- SEC-reported price per share
- $0.14
- Number of holders
- 1
- Value change
- -$1,362,733
- Number of buys
- 1
- Number of sells
- 34
- Shares outstanding
- 202,086,020
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
1
Top holders
1
GRTX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2024
Previous quarter: Q1 2024
Galera Therapeutics, Inc. SEC filings
Galera Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 36338D108
Recent filing periods:
Ownership snapshot
Top reported holders of GRTX - Galera Therapeutics, Inc. - Common stock, par value $0.001 per share (the "Common Stock") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
GSA CAPITAL PARTNERS LLP
Disclosed value leader
GSA CAPITAL PARTNERS LLP
Comparable rows
15/15
Latest evidence
31 Mar 2024
13F
Lead comparable stake: 1.8%
Showing 1-6 of 15 holder rows.
Quick read
GSA CAPITAL PARTNERS LLP leads the comparable SEC ownership view at 1.8%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens GSA CAPITAL PARTNERS LLP's linked filing trail.
Comparable ownership
Top 5
GSA CAPITAL PARTNERS LLP
1.8%
Blackstone Inc.
0.83%
Aberdeen Group plc
0.44%
Nan Fung Group Holdings Ltd
0.3%
VANGUARD GROUP INC
0.22%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| GSA CAPITAL PARTNERS LLP |
13F
Company
|
1.8%
|
$509,000
3,632,627 shares
|
— | 31 Mar 2024 |
| Blackstone Inc. |
13F
Company
|
0.83%
|
$235,058
1,678,984 shares
|
— | 31 Mar 2024 |
| Aberdeen Group plc |
13F
Company
|
0.44%
|
$125,772
898,374 shares
|
— | 31 Mar 2024 |
| Nan Fung Group Holdings Ltd |
13F
Company
|
0.3%
|
$85,851
613,223 shares
|
— | 31 Mar 2024 |
| VANGUARD GROUP INC |
13F
Company
|
0.22%
|
$62,766
448,330 shares
|
— | 31 Mar 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.22%
|
$61,674
440,349 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
52,113
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
35
Q2 2024 holders
1
Holder diff
-34
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend